Podcast
How To Balance Risk-Taking with Quality in Vaccine Development: Valneva External Manufacturing Interview
“In Big Pharma, innovation is often stifled because the bureaucracy and mindset completely kills creativity and intuition needed for discovery. That’s why they now prefer to allocate their early-phase resources to smaller biotechs,” explains Julien Laizé, sharing candid insights about
27 April 2025